New anti-tuberculosis drugs in clinical trials with novel mechanisms of action
Tuberculosis is a major health problem worldwide, with approximately 1.7 million people dying annually from the disease. The long current drug regimen, the emergence of drug resistant strains and HIV co-infection have resulted in a resurgence in research efforts to address the urgent need for new an...
| Main Authors: | , |
|---|---|
| Format: | Journal Article |
| Published: |
Elsevier Science Ltd
2008
|
| Online Access: | http://hdl.handle.net/20.500.11937/41035 |